← FDA Drug Approvals (Drugs@FDA)

QULIPTA

NDA · New Drug Application · Sponsor: ABBVIE · Approved 2021-09-28

Drug application

FDA Application #

NDA215206

Application type

New Drug Application

Brand name

QULIPTA

Generic name

ATOGEPANT

Active ingredients

ATOGEPANT

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

ABBVIE

Manufacturer

AbbVie Inc.

First approval

2021-09-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown